TED-347 (TED347) is a novel, covalent/irreversible, and allosteric YAP-TEAD protein-protein interaction inhibitor with anticancer activity. It inhibits TEAD4-Yap1 protein-protein interaction with an EC50 of 5.9 μM. It acts by covalently binding to Cys-367 within the central pocket of TEAD4 with a Ki of 10.3 μM, thus blocking TEAD transcriptional activity.
Physicochemical Properties
| Molecular Formula | C15H11CLF3NO |
| Molecular Weight | 313.7022 |
| Exact Mass | 313.048 |
| CAS # | 2378626-29-8 |
| Related CAS # | 2378626-29-8; |
| PubChem CID | 137796964 |
| Appearance | Light yellow to green yellow solid powder |
| LogP | 5.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 21 |
| Complexity | 361 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | ClC([H])([H])C(C1=C([H])C([H])=C([H])C([H])=C1N([H])C1=C([H])C([H])=C([H])C(C(F)(F)F)=C1[H])=O |
| InChi Key | JPVDFGYNLUBCSD-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C15H11ClF3NO/c16-9-14(21)12-6-1-2-7-13(12)20-11-5-3-4-10(8-11)15(17,18)19/h1-8,20H,9H2 |
| Chemical Name | 2-chloro-1-[2-[3-(trifluoromethyl)anilino]phenyl]ethanone |
| Synonyms | TED347 TED 347 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | The motility of GBM43 sperm is inhibited by TED-347 (0.5-100 μM; 48 hours) [1]. The co-immunoprecipitation of Myc-tagged TEAD4 and FLAG-tagged Yap1 is inhibited by TED-347 (5 μM; 48 hours) [1]. The calibrator levels are significantly reduced in -347 (10 μM; 48 hours) CTGF [1]. Cells transfected with the TEAD reporter gene exhibit decreased reporter activity in response to TED-347 (0.5-100 μM; 24 hours). In GBM43 cells, TED-347 (0.5-100 μM) also suppresses TEAD4 transcriptional activity [1]. TED-347 exhibits the same level of efficacy as TEAD2 inhibition and is selective for TEADs. It has been observed that TED-347 (0.1-100 μM; 24-48 hours) mimicking TED-347 (1-100 μM) did not inhibit Cav2.2 αβ protein-protein reactions or uPAR uPA. The precision of TEAD4 Yap1 binding affinity is impacted by the non-covalent binding of TED-347 to TEAD4 [1]. TED-347 exhibits a response t1/2∞ of 18.2 hours and a maximal inactivation of 0.038 hours [1]. |
| Cell Assay |
Cell viability assay [1] Cell Types: GBM43 glioblastoma cell line Tested Concentrations: 0.5, 1, 10, 100 μM Incubation Duration: 48 hrs (hours) Experimental Results: Inhibited GBM43 cancer cell viability, inhibited GBM43 cell viability by 30% at 10 μM. Western Blot Analysis[1] Cell Types: HEK-293 Cell Tested Concentrations: 5 μM Incubation Duration: 48 hrs (hours) Experimental Results: Significant loss of Myc-tagged TEAD4 co-immunoprecipitated with FLAG-tagged Yap1. RT-PCR[1] Cell Types: HEK-293 Cell Tested Concentrations: 10 μM Incubation Duration: 48 hrs (hours) Experimental Results: CTGF transcript levels were Dramatically diminished compared to control cells and had negative effects on TEAD mutant transcriptional activity and protein-protein interactions Cell culture was not inhibited. |
| References |
[1]. Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD⋅Yap Protein-Protein Interaction. Cell Chem Biol. 2019 Mar 21;26(3):378-389.e13. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~100 mg/mL (~318.78 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 6.25 mg/mL (19.92 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 62.5 mg/mL clear DMSO stock solution to 900 μL corn oil and mix evenly. Solubility in Formulation 2: 2.5 mg/mL (7.97 mM) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.1878 mL | 15.9388 mL | 31.8776 mL | |
| 5 mM | 0.6376 mL | 3.1878 mL | 6.3755 mL | |
| 10 mM | 0.3188 mL | 1.5939 mL | 3.1878 mL |